These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8049566)

  • 41. An animal model of antibody binding in cutaneous lupus.
    Lee LA; Weston WL; Krueger GG; Emam M; Reichlin M; Stevens JO; Surbrugg SK; Vasil A; Norris DA
    Arthritis Rheum; 1986 Jun; 29(6):782-8. PubMed ID: 3521613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein.
    Scofield RH; Racila DM; Gordon TP; Kurien BT; Sontheimer RD
    J Rheumatol; 2000 Jan; 27(1):128-34. PubMed ID: 10648028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
    Provost TT; Watson R
    J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A major autoepitope is present on the amino terminus of a human SS-A/Ro polypeptide.
    Lieu TS; Newkirk MM; Arnett FC; Lee LA; Deng JS; Capra JD; Sontheimer RD
    J Autoimmun; 1989 Aug; 2(4):367-74. PubMed ID: 2477002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C1q inhibits autoantibody binding to calreticulin.
    Racila DM; Sontheimer RD
    Lupus; 1999; 8(4):300-4. PubMed ID: 10413209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Presence of anti-La(SS-B) is associated with binding to the 13-kD carboxyl terminus of 60-kD Ro(SS-A) in systemic lupus erythematosus.
    Dickey WD; van Egmond JE; Hardgrave KL; Harley JB; Scofield RH
    J Invest Dermatol; 1993 Apr; 100(4):412-6. PubMed ID: 8454905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The SS-A/SS-B autoantigenic complex: localization and assembly.
    Peek R; van Venrooij WJ; Simons F; Pruijn G
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S15-8. PubMed ID: 7539348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ro(SS-A) and anti-Ro(SS-A): an update.
    Sibilia J
    Rev Rhum Engl Ed; 1998 Jan; 65(1):45-57. PubMed ID: 9523386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of Ro/SS-A antigen in human skin and heart.
    Deng JS; Sontheimer RD; Gilliam JN
    J Invest Dermatol; 1985 Nov; 85(5):412-6. PubMed ID: 3932521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.
    Provost TT; Talal N; Bias W; Harley JB; Reichlin M; Alexander EL
    J Invest Dermatol; 1988 Oct; 91(4):369-71. PubMed ID: 3262691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiological roles of calreticulin in autoimmune disease.
    Eggleton P; Llewellyn DH
    Scand J Immunol; 1999 May; 49(5):466-73. PubMed ID: 10320638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen.
    Boehm J; Orth T; Van Nguyen P; Söling HD
    Eur J Clin Invest; 1994 Apr; 24(4):248-57. PubMed ID: 8050453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultraviolet light-induced augmentation of SS-A/Ro.
    J Invest Dermatol; 1991 Sep; 97(3):604-5. PubMed ID: 1875059
    [No Abstract]   [Full Text] [Related]  

  • 54. [The Ro/SS-A antigen-antibody system].
    Mayet WJ; Bachmann M; Hermann E; Poralla T; Müller WE; Meyer zum Büschenfelde KH
    Z Rheumatol; 1988; 47(2):80-5. PubMed ID: 3291481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus.
    Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA
    J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity.
    Chen X; Wolin SL
    J Mol Med (Berl); 2004 Apr; 82(4):232-9. PubMed ID: 15168680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracellular localization and nucleocytoplasmic transport of Ro RNP components.
    Pruijn GJ; Simons FH; van Venrooij WJ
    Eur J Cell Biol; 1997 Oct; 74(2):123-32. PubMed ID: 9352217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.
    Scofield RH; Farris AD; Horsfall AC; Harley JB
    Arthritis Rheum; 1999 Feb; 42(2):199-209. PubMed ID: 10025913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of calcium binding by Ro 60 multiple antigenic peptides on nitrocellulose membrane using Quin-2-.
    Kurien BT; Bachmann M
    Methods Mol Biol; 2009; 536():483-90. PubMed ID: 19378085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies.
    Ben-Chetrit E
    Br J Rheumatol; 1993 May; 32(5):396-402. PubMed ID: 8495261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.